(February 27 08:38) Tech.einnews.com
… proprietary mesenchymal lineage cell therapy technology platform to establish a broad … rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being … Australia, the United States and Singapore and is listed on the …
You can find the original article
here